VIENNA, November 2021: Co-Founder Dr. Nikolaus Gasche has been recognised as one of the top…
Barbara SladekJanuary 24, 2022
BiomeDx presents newest findings on microbiome signatures predicting immune checkpoint inhibitor therapy response. GRAZ, October…
Nikolaus GascheOctober 27, 2021
BiomeDx presents first meta-analysis for predicting immune checkpoint inhibitor therapy response. VIENNA, October 11th, 2021:…
Nikolaus GascheOctober 12, 2021
BiomeDx was invited to present its own research and discuss microbiome and nutrigenetics. September 29th,…
Nikolaus GascheSeptember 29, 2021
VIENNA, September 2021 We are happy to announce that the recruitment for our clinical research…
Nikolaus GascheSeptember 7, 2021
VIENNA, March 2021 Are you a tech company developing software for the medical field? Awesome!…
Nikolaus GascheMarch 10, 2021